Cerluten: clinical report on a tissue-derived preparation
Comparison in people · 2006
- What was studied
- 85 patients: 48 adjunctive Cerluten; 37 conventional-care controls. Mixed neurological diagnoses.
- Main finding
- The 2005–2006 report describes attention-test and selected EEG improvements during 10–20 days of adjunctive treatment.
Study data at a glance
- Participants or experimental model
- 85 patients: 48 adjunctive Cerluten; 37 conventional-care controls. Mixed neurological diagnoses.
- Reported results
- The 2005–2006 report describes attention-test and selected EEG improvements during 10–20 days of adjunctive treatment.
Study limitations and source details
Study limitations
- Random allocation and blinding are not documented. EEG assessment selected more severely affected patients; the findings cannot establish stroke recovery or benefit in healthy people.
- Commercially reproduced institute report; independent peer review and independent replication are not established by this document.
- Short-term reporting without a complete adverse-event protocol cannot establish long-term safety. Preparation equivalence to current products or synthetic peptides is unproven.
Source details
Institute report — commercial reproduction
Russian report reproduced on a commercial website; population, comparison and reported outcomes checked. Signed original and full protocol not authenticated.
Sources checked
Citation
Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution). Cerluten: clinical report on a tissue-derived preparation Institute clinical report (commercial reproduction); 2006 study/report date, not website publication date